Ventyx Biosciences, Inc. Profile Avatar - Palmy Investing

Ventyx Biosciences, Inc.

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that i…

Biotechnology
US, Encinitas [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of VTYX's Analysis
CIK: 1851194 CUSIP: 92332V107 ISIN: US92332V1070 LEI: - UEI: -
Secondary Listings
VTYX has no secondary listings inside our databases.